2010 Annual Scientific Meeting and Exposition 2010 Annual ...

MAY 1PostersSaturday AfternoonPO-38: 3PO-39: 3PO-40: 3PO-41: 3PO-42: 3PO-43: 3Aliskiren/Amlodipine Combination ReducesCentral Blood Pressure More than AmlodipineAlone in African Americans with Stage 2HypertensionJoseph Izzo†, 1 M. Weinberger, 2 M. Israel, 3 R. Hilkert, 3D. Purkayastha, 3 J. Lee, 3 H. Black. 4 1 State University ofNew York at Buffalo, US; 2 Indiana University MedicalCenter, US; 3 Novartis Pharmaceuticals, US and 4 NewYork University, US.24-Hour Efficacy and Safety of Full-Dose, TriplecombinationTherapy with Olmesartan, Amlodipine,and HydrochlorothiazideJoseph Izzo†, 1 Michael Melino, 2 Victor Fernandez, 2James Lee, 2 Reinilde Heyrman. 2 1 State University ofNew York at Buffalo, Buffalo, NY, US and 2 DaiichiSankyo, Inc, Parsippany, NJ, US.Initial Combined Valsartan/HCTZ Therapy vs EitherComponent as Monotherapy in Elderly Individualswith Systolic Hypertension: Age-Stratified Analysisof the Valvet StudyJ. L. Izzo, Jr.†, 1 D. Duprez, 2 H. Weintraub, 3 R. Samuel, 4D. Purkayastha, 4 D. Zappe, 4 W. Cushman. 5 1 StateUniv. of New York at Buffalo, US; 2 Univ. Minnesota,US; 3 NYU School of Medicine, US; 4 Novartis, US and5 Univ. Tennessee, US.Efficacy and Tolerability of Combined AngiotensinReceptor Blocker+Diuretic Therapy vs Monotherapywith Either Component in Elderly Individuals withSystolic Hypertension: Results from ValvetJ. L. Izzo, Jr.†, 1 H. Weintraub, 2 D. Duprez, 3 R. Samuel, 4D. Purkayastha, 4 D. Zappe, 4 W. Cushman. 5 1 SUNYBuffalo, US; 2 NYU School of Medicine, US; 3 Univ.Minnesota, US; 4 Novartis, US and 5 Univ. Tennessee,US.Effects of Thiazide Diuretics on Bone MineralDensity in Hypertensive Elderly African AmericanWomenFahad Javed, Emad F. Aziz, Shahzeb Khan, RamyaSuryadevara, Iffat Shaheen, Carlos Alviar, JorgeRomero, Alexandre Benjo, Eyal Herzog, Franz H.Messerli. St Lukes Roosevelt Hosp Ctr/Univ Hospitalfor Coll of Physicians & Surgeons of Columbia Univ,New York, US.Immunoreactive Active Renin Alone Does NotPredict Antihypertensive Efficacy of Direct ReninInhibitorsCharlotte Jones-Burton†, 1 Yabing Mai, 1 JosephRubino, 1 Marc Bellet, 2 Jasper Dingemanse, 2 MichaelStepanavage, 1 Peter Feig. 1 1 Merck, US and 2 Actelion,CH.1 Pathobiology Track 2 Translational Track 3 Therapy Track110